DOCTOR CHOCO
LIVE

Serial Number

79182058

Owner

VULM s.r.o.

Filing Date

Nov 3, 2015

Add to watchlist:

No watchlists yet
View on USPTO

DOCTOR CHOCO Trademark

Serial Number: 79182058 • Registration: 5135022

DOCTOR CHOCO is a trademark filed by VULM s.r.o. on November 3, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

VULM s.r.o. (3 trademarks)

Tuhovská 18

Entity Type: 98

VULM SK s.r.o. (5 trademarks)

Tuhovská 18
Bratislava SK-831 06 , SK

Entity Type: 16

Trademark Details

Filing Date

November 3, 2015

Registration Date

February 7, 2017

Published for Opposition

November 22, 2016

Cancellation Date

November 3, 2025

Goods & Services

Nutritional supplements; syrups for pharmaceutical purposes for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; pharmaceutical preparations for treatment of cough, cough compulsion, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; chemico-pharmaceutical preparations for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; vitamin preparations; chemical preparations for medical use in the form of solutions, syrups, drops, liquid preparations, suspensions, emulsions for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; chemical preparations for pharmaceutical use, specifically for the treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; biological preparations for medical purposes in the form of solutions, syrups, drops, liquid preparations, suspensions, emulsions for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; malted milk beverages for medical use; human medicine for the treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; medicines for veterinary use for the treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; medicinal tea; medicinal drinks

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 28, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 28, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
May 12, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 18, 2024 INTS
INVALIDATION PROCESSED
Apr 18, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 18, 2024 INTR
CANCELLED SECTION 71
Aug 18, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 7, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 23, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 4, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 3, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 7, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 17, 2016 PREV
CHANGE OF OWNER RECEIVED FROM IB
Oct 15, 2016 CHLD
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2016 CRFA
ASSIGNED TO LIE
Aug 23, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2016 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 16, 2016 TCCA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 28, 2016 NREP
REFUSAL PROCESSED BY IB
Mar 11, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 25, 2016 RFCS
REFUSAL PROCESSED BY MPU
Feb 25, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 25, 2016 RFCR
NON-FINAL ACTION WRITTEN
Feb 24, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 20, 2016 MAFR
ASSIGNED TO EXAMINER
Feb 16, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 11, 2016 REPR